Clinical results show that the AxioMed discs display superior strength, durability and enhanced range of motion when compared to that of a healthy, human disc.
Boston, MA (PRWEB) December 02, 2015
There have been many surgeons lamenting the lack of innovation at national spine conferences. “We aim to change that perception starting with the CSRS meeting this year in San Diego,” says Dr. Kingsley R. Chin, Orthopaedic Spine Surgeon and CEO of KICVentures. Dr. Chin is a Henry Bohlman fellowship-trained spine surgeon who has the same strong interest in cervical spine surgery as his mentor, so it was no surprise when he convinced the KICVentures team to acquire AxioMed Corporation in November 2014.
Dr. Chin will be attending the CSRS (Cervical Spine Research Society) meeting in San Diego, CA on Friday, December 4th and Saturday, December 5th to meet with other surgeons who have shown an interest in bringing the AxioMed viscoelastic total disc replacement technology to the U.S. Market to initiate IDE trials in 2016.
AxioMed’s total disc replacement, the Freedom® Disc, is a single-piece technology made of proprietary polymer that is permanently bonded between two titanium discs. Its viscoelastic core simulates the stability and flexibility of a healthy human disc. The Freedom Disc has been implanted in over 800 patients globally and has performed well on the European market. Clinical results show that the AxioMed discs display superior strength, durability and enhanced range of motion when compared to that of a healthy, human disc.
“This technology is the next generation of total disc replacements and is designed to mimic the natural anatomy of a human disc. Unlike current discs on the market that are miniaturized versions of a total knee replacement ball and socket joints, the AxioMed lumbar and cervical discs are compressible, single-piece devices with no moving parts. The proprietary viscoelastic material is the only proven material to perform as a disc replacement in the spine and KICVentures has the exclusive license in the spine for its lumbar and cervical discs and any other applications. We want to bring back the excitement and optimism for disc replacement that we experienced in 2004 with the introduction of the first FDA cleared lumbar disc replacement,” says Dr Chin.
The Freedom Disc has received global attention. Dr. Pflugmacher, Head of Spine Orthopedics, University Hospital of Bonn, Germany, calls the Freedom Disc the “best disc on the market.” The lumbar disc IDE trials are coming to an end in a few months and AxioMed plans to submit the PMA to the FDA in 2016 and hopes to release the lumbar disc in the USA in 2017. The disc is available outside the USA and is exclusively distributed by http://www.spinefrontier.com.
Founded in 2001, AxioMed began its journey of exhaustively proving the Freedom Disc through research, development and testing. In 2014, KICVentures recognized the disc’s enormous potential and acquired the company into their healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology. Visit AxioMed at: http://www.axiomed.com.
KICVentures manages several portfolio companies, investing in disruptive technology in the health-tech sector. KICVentures acquires, creates, and nurtures companies and their technologies to their fullest potential. Visit KICVentures at: http://www.KICVentures.com.